Transforming pharmaceutical education to accelerate the acceptance and implementation of personalized medicine

American Journal of Pharmaceutical Education

Volumn 75, Issue 6, 2011, Pages

  McKinnon, Ross ^a   Anderson, Claire ^b  

^a FLINDERS UNIVERSITY   (Australia)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOTECHNOLOGY; CURRICULUM; DRUG THERAPY; EDUCATION; HEALTH CARE COST; HUMAN; PERSONALIZED MEDICINE; PHARMACIST; PHARMACOGENETICS; PHARMACY;

BIOTECHNOLOGY; COMMUNITY PHARMACY SERVICES; CURRICULUM; DRUG THERAPY; EDUCATION, PHARMACY; HEALTH CARE COSTS; HUMANS; INDIVIDUALIZED MEDICINE; PHARMACISTS; PHARMACOGENETICS;

EID: 80051647864     PISSN: 00029459     EISSN: 15536467     Source Type: Journal    
DOI: 10.5688/ajpe756107     Document Type: Article

References (10)

1. McKinnon RA, Ward MB, Sorich MJ. A critical analysis of barriers to the implementation of pharmacogenomics into clinical practice. Therapeutics Clin Risk Manage. 2007;3(5): 751-759.
2. Final Report of the 2007-2008 Bylaws and Policy Development Committee. American Association of Colleges of Pharmacy. http://www.ajpe.org/view.asp?art5aj7206S16&pdf5yes. Accessed July 2, 2011.
3. Murphy JE, Green JS, Adams LA, et al. Pharmacogenomics in the curricula of colleges and schools of pharmacy in the United States. Am J Pharm Educ. 2010;74(1):1-10.
4. Brock TP, Faulkner CM, Williams DM, Smith, SR. Continuing education programs in pharmacogenomics for pharmacists. Am J Health-System Pharm. 2002;59(8):722-725.
5. Clemerson J, Payne K, Bissell P, Anderson C. Pharmacogenetics, the next challenge for pharmacy? Pharm World Sci. 2006;28(3):126-130.
6. Clemerson J, Payne K. Pharmacogenetics-background and future potential. Hospital Pharmacist. 2008;15(5):59-62.
7. Martin P, Morrison M, Realising the potential of genomic medicines. University of Nottingham: Institute for the Study of genetics, Biorisk and Society. London Pharmacy Practice Research Trust, 2006.
8. Plevin DP, Ward H, Ward MB, Sorich MJ, McKinnon RA. Targeted cancer Australia: clinical therapies in practice, pharmacy education and future directions. Am J Pharm Educ. 2010;74(9):168.
9. Corkindale D, Ward H, McKinnon, R. Low adoption of pharmacogenetic testing: an exploration and explanation of the reasons in Australia. Personalized Med. 2007;2: 191-199.
10. Anderson C, Bates I, Beck D, Brock TP, Futter B, Mercer H, Rouse M, Whitmarsh S, Wuliji T, Yonemura A. The WHO UNESCO FIP Pharmacy Education Taskforce Human Resources for Health. 2009;7:45.